ArticleClinical epidemiology2026

Use of Negative Control Outcomes to Assess Cohort Comparability Among Evolocumab Initiators: A Real-World Database Study.

Yue Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.